BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23369209)

  • 1. Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage.
    Tai CJ; Su TC; Jiang MC; Chen HC; Shen SC; Lee WR; Liao CF; Chen YC; Lin SH; Li LT; Shen KH; Yeh CM; Yeh KT; Lee CH; Shih HY; Chang CC
    J Transl Med; 2013 Jan; 11():29. PubMed ID: 23369209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression.
    Jiang MC; Yeh CM; Tai CJ; Chen HC; Lin SH; Su TC; Shen SC; Lee WR; Liao CF; Li LT; Lee CH; Chen YC; Yeh KT; Chang CC
    Am J Surg; 2013 Sep; 206(3):418-27. PubMed ID: 23806821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer.
    Alnabulsi A; Agouni A; Mitra S; Garcia-Murillas I; Carpenter B; Bird S; Murray GI
    J Pathol; 2012 Dec; 228(4):471-81. PubMed ID: 22450763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of CSE1L Gene in Colorectal Cancer Reduces Tumorigenesis in Vitro.
    Pimiento JM; Neill KG; Henderson-Jackson E; Eschrich SA; Chen DT; Husain K; Shibata D; Coppola D; Malafa MP
    Am J Pathol; 2016 Oct; 186(10):2761-8. PubMed ID: 27521996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of nuclear CSE1L in urinary bladder urothelial carcinomas.
    Chang CC; Tai CJ; Su TC; Shen KH; Lin SH; Yeh CM; Yeh KT; Lin YM; Jiang MC
    Ann Diagn Pathol; 2012 Oct; 16(5):362-8. PubMed ID: 22476051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential distributions of CSE1L/CAS and E-cadherin in the polarized and non-polarized epithelial glands of neoplastic colorectal epithelium.
    Uen WC; Tai CJ; Shen SC; Lee WR; Tsao TY; Deng WP; Chiou HY; Hsu CH; Hsieh CI; Liao CF; Jiang MC
    J Mol Histol; 2010 Oct; 41(4-5):259-66. PubMed ID: 20734115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of cytoplasmic phosphorylated CSE1L in malignant melanoma but not in benign nevi: phosphorylated CSE1L for the discrimination between melanoma and benign nevi.
    Chin SY; Wu PR; Shih YH; Yeh CM; Lee WR; Shen SC; Yeh KT; Jiang MC; Tseng JT
    Int J Clin Exp Pathol; 2015; 8(2):1393-401. PubMed ID: 25973023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cellular apoptosis susceptibility protein is a potential prognostic marker for metastatic colorectal cancer.
    Stella Tsai CS; Chen HC; Tung JN; Tsou SS; Tsao TY; Liao CF; Chen YC; Yeh CY; Yeh KT; Jiang MC
    Am J Pathol; 2010 Apr; 176(4):1619-28. PubMed ID: 20150437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between CSE1L expression and axillary lymph node metastasis in breast cancer.
    Yuksel UM; Dilek G; Dogan L; Gulcelik MA; Berberoglu U
    Tumori; 2015; 101(2):194-8. PubMed ID: 25791533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.
    Sillars-Hardebol AH; Carvalho B; Beliën JA; de Wit M; Delis-van Diemen PM; Tijssen M; van de Wiel MA; Pontén F; Meijer GA; Fijneman RJ
    Cell Oncol (Dordr); 2012 Aug; 35(4):293-300. PubMed ID: 22711543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Function of CSE1L/CAS in the secretion of HT-29 human colorectal cells and its expression in human colon.
    Tsao TY; Tsai CS; Tung JN; Chen SL; Yue CH; Liao CF; Wang CC; Jiang MC
    Mol Cell Biochem; 2009 Jul; 327(1-2):163-70. PubMed ID: 19224336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does CSE1L Overexpression Affect Distant Metastasis Development in Breast Cancer?
    Yuksel UM; Turker I; Dilek G; Dogan L; Gulcelik MA; Oksuzoglu B
    Oncol Res Treat; 2015; 38(9):431-4. PubMed ID: 26278417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer.
    Ma S; Yang D; Liu Y; Wang Y; Lin T; Li Y; Yang S; Zhang W; Zhang R
    Aging (Albany NY); 2018 Aug; 10(8):2062-2078. PubMed ID: 30144787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells.
    Lorenzato A; Biolatti M; Delogu G; Capobianco G; Farace C; Dessole S; Cossu A; Tanda F; Madeddu R; Olivero M; Di Renzo MF
    Exp Cell Res; 2013 Oct; 319(17):2627-36. PubMed ID: 23948303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells.
    Liao CF; Luo SF; Li LT; Lin CY; Chen YC; Jiang MC
    J Exp Clin Cancer Res; 2008 Jul; 27(1):15. PubMed ID: 18597698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer.
    Chang CC; Kao WY; Liu CY; Su HH; Kan YA; Lin PY; Ku WC; Chang KW; Yang RN; Huang CJ
    Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35417036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells.
    Liao CF; Lin SH; Chen HC; Tai CJ; Chang CC; Li LT; Yeh CM; Yeh KT; Chen YC; Hsu TH; Shen SC; Lee WR; Chiou JF; Luo SF; Jiang MC
    Mol Med; 2012 Dec; 18(1):1269-80. PubMed ID: 22952058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells.
    Nagashima S; Maruyama J; Honda K; Kondoh Y; Osada H; Nawa M; Nakahama KI; Ishigami-Yuasa M; Kagechika H; Sugimura H; Iwasa H; Arimoto-Matsuzaki K; Nishina H; Hata Y
    J Biol Chem; 2021 Jul; 297(1):100803. PubMed ID: 34022224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis.
    Tai CJ; Hsu CH; Shen SC; Lee WR; Jiang MC
    J Exp Clin Cancer Res; 2010 Aug; 29(1):110. PubMed ID: 20701792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of CSE1L protein in urine of patients with urinary bladder urothelial carcinomas.
    Tai CJ; Liao CF; Su TC; Shen KH; Chang CC; Lin SH; Yeh CM; Shen SC; Lee WR; Chiou JF; Lin CH; Chen YC; Shih HY; Yeh KT; Jiang MC
    Int J Biol Markers; 2012 Oct; 27(3):e280-4. PubMed ID: 22653741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.